Bacterial DNA (DNA) (DNA)

Bacterial DNA is the fundamental genetic material of prokaryotic organisms, containing the instructions necessary for cellular function, growth, and reproduction (StatPearls, 2023). In the context of antimicrobial therapy, it serves as a direct molecular target for the drug clofazimine, which is primarily used to treat mycobacterial infections such as leprosy and multidrug-resistant tuberculosis. Clofazimine binds preferentially to the guanine bases of the bacterial genome, thereby inhibiting the DNA's template function and blocking essential processes like replication and transcription (DrugBank, 2024). This interaction leads to the cessation of bacterial growth and contributes to the drug's bactericidal effects. Additionally, the binding of clofazimine to DNA is associated with the generation of reactive oxygen species and interference with the bacterial respiratory chain, further compromising the pathogen's viability (PubChem, 2024). As a target, bacterial DNA is critical for the efficacy of riminophenazine compounds in managing chronic and resistant infections.

Other names

Bacterial DNA – clofazimine componentBacterial genomeDeoxyribonucleic acidMycobacterial DNA

Clofazimine binds preferentially to the guanine bases of bacterial DNA, which inhibits the template function of the DNA and blocks bacterial replication and transcription (StatPearls, 2023; DrugBank, 2024). Additionally, the drug promotes the generation of antimicrobial reactive oxygen species and interferes with the bacterial respiratory chain (PubChem, 2024).